While considerable progress has been made in understanding the events by which eosinophils accumulate in various pathophysiological conditions, the mechanisms controlling the resolution of eosinophilic inflammation are poorly understood. In the present study, we demonstrate that lung eosinophils obtained by bronchoalveolar lavage (BAL) after aerosol allergen provocation of immunized mice expressed the Fas receptor. Stimulation of purified eosinophils in vitro with a monoclonal anti-Fas mAb (1 ng-1 ,ug/ml) induced a dose/time dependent loss of cell viability from 24-72 h. Measurement of DNA fragmentation with propidium iodide, confirmed that anti-Fas induced eosinophil death by apoptosis. While incubation with IL-3, IL-5, or GM-CSF prevented spontaneous apoptosis, these factors failed to prevent anti-Fas induced apoptosis. Administration of anti-Fas mAb to the lungs after the induction of a lung eosinophilia increased the number of peroxidase positive macrophages in BAL fluid 4-12 h later which was followed by a marked reduction in the number of eosinophils in the airways. Importantly, Fas-mediated resolution of eosinophilic inflammation occurred in the absence of any overt secondary inflammatory changes in the lungs. We speculate that defects in this pathway may at least in part explain the chronic eosinophilic inflammation often observed in the lungs of asthmatic individuals. (J. Clin. Invest. 1995. 96:2924-2931 
Introduction
The accumulation and activation of eosinophils, with the subsequent release of highly toxic cationic proteins, is believed to be important in the pathogenesis of bronchial asthma (1, 2) . Recent studies performed in experimental animals have suggested that eosinophil infiltration into the airways is dependent on IL-5 derived from the Th2 subset of CD4+ T cells (3, 4) . However, there is little information concerning the events that govern the resolution of the eosinophilic inflammatory response. An appreciation of these processes is central in understanding whether an inflammatory response is either acute and self-resolving or becomes chronic and self-perpetuating. In vitro, eosinophil survival is maintained by the eosinophil haematopoietins, IL-3, IL-5 and GM-CSF, which prevent programmed cell death or apoptosis (5, 6 ), a process accompanied by condensation of the cytoplasm, segmentation of the nucleus and extensive degradation of chromosomal DNA. However, it is unclear if eosinophil death only occurs passively following withdrawal/ absence of the eosinophil survival factors, or whether mechanisms exist to actively induce eosinophil apoptosis.
The cell surface molecule Fas/Apo-1 (CD95) is a 45 kD protein belonging to the TNF/NGF receptor family (7) . Crosslinking of the Fas receptor with monoclonal antibodies or its recently identified ligand, Fas Ligand (FasL) leads to the induction of apoptosis in lymphocytes (8) (9) (10) (11) and provides a mechanism for the removal of antigen activated T cells (12) (13) (14) and autoreactive B cells (15) . The importance of this pathway in the regulation of lymphocyte apoptosis is illustrated in mice homozygous for either lpr (7, 9) or gld (11) mutations, which lack functional Fas receptor and FasL respectively and develop similar auto immune responses and accumulate a large number of non malignant CD4 -CD8 -T cells in the spleen.
There is now increasing evidence to suggest that cell death mediated by apoptosis is also of major importance in the resolution of inflammatory responses (16) . Resolution of inflammation would require swift recognition of effete cells to insure against the detrimental consequences to the surrounding tissue that would follow if cell disintegration or necrosis occurred (16) . In view of the relationship between apoptosis and the resolution of inflammatory responses, we have investigated whether murine lung eosinophils express the Fas receptor and undergo apoptosis following receptor crosslinking. Moreover, we have determined whether administration of anti-Fas mAb in vivo after the establishment of an airway eosinophilic response would lead to the resolution of lung eosinophilic inflammation.
Methods
Induction and purification of lung eosinophils. To induce a lung eosinophilia, Sv 129 mice (20-25 grams) were immunized i.p. with 10 Jtg of ovalbumin (OA), (Grade V; Sigma Chemical Co., St. Louis, MO) in 0.2 ml of alum (Serva, Heidelberg, Germany) on day 0 and day 14. 7-10 d after the last immunization, animals were challenged with an aerosol of OA (50 mg/ml) for 20 min as described previously (4) . 72 h after antigen inhalation, mice were anesthetized with urethane (Sigma Chemical Co.), the trachea cannulated and a bronchoalveolar lavage (BAL) performed by 10 All antibodies were applied in 50 Ml PBS. 48 h later, a BAL was performed and the cellular composition determined. Blood was also taken from the tail vein at each of these time points, total leukocyte counts determined (Sysmex; Toa Medical Electronics Co., Ltd., Kobe, Japan) and blood smears prepared. Slides were stained with Dif-Quik3'5 (Baxter Diagnostics, Dudingen, Switzerland) and a total of 500 cells counted differential using standard histological criteria.
Lung Histology. 48 h after lung application of either anti-Fas mAb (50 Mg) or control isotype matched mAb in immunized, antigen challenged mice, the lungs were prepared for histological examination. Mice were anesthetised with urethane, the trachea cannulated, the chest opened and the lungs perfused via the trachea with 4% buffered formaldehyde in PBS (pH 7.0, formal saline) at exactly 15 cm H20 maintained by a pressure seal for 60 min. The fixed lungs were trimmed of the heart and large blood vessels and removed en bloc into formal saline and processed into paraffin. 15-MLM sections were cut and stained with hematoxylin and eosin. Stained and coded slides were examined under low power ( x 100) to study gross histopathological changes and regions of interest further studied and photographed using a Zeiss Axiophoto photomicroscope at higher magnification.
Ex vivo macrophage recognition assay. To understand more fully how anti-Fas mAb leads to the resolution of the lung eosinophilic inflammatory response, we administered a submaximal dose (20 
Results
Lung eosinophils express the Fas receptor. Antigen provocation of OA immunized mice resulted in a selective eosinophil infiltration into the lungs 72 h later, constituting > 70% of the total cell population. Removal of macrophages by adherence increased the eosinophil purity to 92-98% in each experiment. Staining with PE-labeled anti-Fas mAb revealed that almost all the lung eosinophils expressed the Fas receptor (mean channel fluorescence for isotype control, 3.9 and PE-labeled anti-Fas mAb, 27.4). Fig. 1 is a representative FACS® analysis of eosinophils purified from the BAL fluid of 6-8 mice. A similar profile was observed in three other separate experiments.
Induction of eosinophil death via apoptosis following Fas receptor activation. After purification, > 98% of the eosinophils were viable as determined by trypan blue exclusion. Over the next 72 h, eosinophils cultured in medium alone resulted in a spontaneous loss of cell viability (72 h: 48.3±4.2% nonviable). Incubation with the matched isotype control had no effect of the loss of cell viability (72 h: 49.7±4.6% nonviable). Incubation with anti-Fas induced a time and dose dependent increase in cell death which became apparent 24 h after culture (Fig. 2  A) . To determine whether anti-Fas induced eosinophil death via apoptosis, eosinophils were stained with PI to measure the degree of DNA fragmentation. After 72 h incubation in medium alone, the percentage of apoptotic cells increased from < 2% after purification to 65.5±4.4%, n = 4, P < 0.01. Incubation with the isotype matched control mAb did not have any significant effect on eosinophil apoptosis (68.2±4.6% apoptotic cells, n = 4. indicating that anti-Fas induced cell death via apoptosis (Fig.  2 B) .
Effect of IL-3, IL-5, and GM-CSF on anti-Fas induced eosinophil apoptosis. 6 h after incubation in medium alone, 27.4±0.7% of the eosinophils were apoptotic. Incubation with 1 ng/ml of either IL-3, I-5, or GM-CSF prevented spontaneously occurring apoptosis at 6 hrs (IL-3, 13.2±0.8%, n = 4, P < 0.05; 11L-5, 14.7+1.0%, n = 4, P < 0.05; GM-CSF, 11.2±0.2%, n = 4, P < 0.05). This difference was more profound after 72 h with 49.6±1.3% of the cells being apoptotic when incubated in medium alone and 18.6±1.0% with 11L-3 (n = 4, P < 0.05), 12.0±1.0% with 11L-5 (n = 4, P < 0.05) and 8.6±0.2% with GM-CSF (n = 4, P < 0.05).
Anti-Fas stimulation induced a comparable proportional increase in DNA fragmentation, when cells were either incubated in medium alone or in the presence of 1 ng/ml of either IL-3, IL-5, or GM-CSF. Likewise incubation of eosinophils with 10-fold higher concentrations of these survival factors failed to prevent anti-Fas induced eosinophil death (data not shown). Representative FACS®D analyses 6 h after anti-Fas stimulation are shown in Fig. 3 and the mean data for DNA fragmentation at 6 and 72 h shown in Fig. 4, A (Fig. Sa) . There was no change in the number of eosinophils in the lung after the administration of the matched isotype control mAb, compared with before mAb administration. Importantly, the resolution of eosinophilic inflammation occurred without any significant change in either the BAL macrophage number (Fig. 5 b) , the number of peripheral blood leukocytes (Fig. 5 c) or peripheral blood eosinophils (Fig. 5 d) . Addition (Fig. 7) . To determine the fate of the eosinophils upon Fas receptor stimulation, we then stained cytospin preparations with DAB-peroxidase. Preliminary experiments demonstrated that macrophages from immunized, non antigen challenged mice failed to stain positive for peroxidase, while 100% of the eosinophils, 72 h after antigen challenge were peroxidase positive. However, 4 and 12 h after anti-Fas administration, the number of peroxidase positive macrophages in the BAL fluid increased from 0.8±0.4% before mAb administration to 11.9±4.5% at 4 h and 15.1±5.1% 12 h later, as compared to isotype mAB treated mice (4 h: 0.5±0.2%, n = 4, P < 0.05; 12 h: 4.3±1.0%, n = 4, P < 0.05), indicative that macrophages had phagocytosed the eosinophils. This is unlikely to be related to a recruitment of immature peroxidase positive macrophages, as neither bone marrow derived or blood monocytes stained positive with DAB peroxidase. Moreover, it is highly unlikely that this increase reflects neutrophil engulfment, as neutrophils at any time point were < 1% of the total BAL population and were also DAB-peroxidase negative. 24 -48 h after administration of anti-Fas the percentage of peroxidase positive macrophages in the anti-Fas treated group was not significantly different from isotype mAb treated mice (Fig. 8) . There was however, a significant increase in the number of peroxidase positive macrophages 24 and 48 h after isotype mAb treatment 4.1±0.95% P < 0.05 and 6.0±1.5%, n = 4, P < 0.05) as compared with time 0 (0.8±0.4%). Representative photomicro- anti-Fas (XI 000) in immunized antigen challenged mice. In mice treated with the isotype control there is a marked subepithelial eosinophil infiltration in the bronchi, which was absent in the anti-Fas treated lungs. Importantly, there is no overt secondary inflammatory changes in the lungs and the airway epithelium appears to be essentially normal.
rally associated with the decrease in eosinophils in the BAL from 12-48 h.
Discussion
Apoptosis induced-cell death is believed to play a major role in the deletion of unwanted T cells in the thymus after their encounter with self-antigens and in the-periphery, where mature antigen-activated lymphocytes are deleted by activation induced cell death (ACID). Activation of cell surface Fas receptor by cognate interactions with cells expressing FasL, transmits a death signal to the target cell and has been shown to play a central role in ACID, although not in T cell thymic apoptosis, as mice homozygous for the lpr mutation, show no impairment in their ability to delete autoreactive lymphocytes (19) . There is now also increasing evidence to suggest that death by apoptosis is of widespread importance in various inflammatory processes and provides a mechanism whereby effete effector cells can be removed from the site of inflammation without damage to the surrounding host tissue ( 12) . It is in this context, we report that lung eosinophils express the Fas receptor, which upon ligation with an anti-Fas mAb, transmits a death signal to the eosinophil, leading to DNA fragmentation followed by loss of cell viability. While eosinophils derived from the airways expressed the Fas receptor, it is unclear whether Fas is also expressed on peripheral blood eosinophils. However, due to the technical limitations in purifying murine peripheral blood eosinophils in the absence of any eosinophil specific surface 0- Figure 7 . ' (28) . Further studies are however required to determine whether Fas mediated resolution of lung eosinophilic inflammation is also associated with a reversal of airway dysfunction.
A major role of the aCvf3 integrin/CD36/thrombospondin receptor system on the surface of the macrophage in the recognition of apoptotic lymphocytes and neutrophils has been suggested (22, 24) . While mAbs against the aCvf3 integrin inhibited the recognition of apoptotic cells by macrophages, other murine monoclonal antibodies of various isotypes and differing specificities failed to promote phagocytosis of freshly isolated cells, suggesting that opsonization of neutrophils or lymphocytes by macrophages could be excluded as a possible recognition mechanism for apoptotic cells (22, 24) . In the present study however, Figure 9 . Photomicrograph showing BAL cells stained with peroxidase 12 h after administration of (a) isotype control or (b) anti-Fas antibody. In the isotype control treated mice, only the eosinophils stain for peroxidase, the macrophages being peroxidase negative. In contrast, after anti-Fas treatment, there is an increase in the number of peroxidase positive macrophages indicating that these cells had engulfed the eosinophils. x600.
in the absence of any hamster anti-murine mAbs that binds to the eosinophils with a different specificity from the Fas receptor, we are unable to rule out the possibility that hamster mAbs in vivo might opsonize eosinophils for macrophages and hence contribute to the resolution of eosinophilic inflammation. Whatever the precise mechanism involved, it is evident that this process is highly efficient, in that 24 h after anti-Fas stimulation, almost 90% of the eosinophils in the lung had been removed. While our study demonstrates that eosinophilic inflammation can be resolved after Fas receptor activation, the question of whether cognate interactions between eosinophils and other cells types (including eosinophils themselves) expressing FasL actually occur in vivo as a pathophysiological mechanism to terminate eosinophilic inflammation still remains to be determined. Antigen activated T lymphocytes have been reported to express FasL and provide one possible killing mechanism Tsuyuki et al. 14). Additionally, recent studies have shown that FasL can be secreted from the cell surface and therefore may transmit a "death signal" at sites distal to the effector cell ( 12) . However, FasL appears to be differentially expressed on lymphocyte subsets in that FasL is present on only the Thl subset, but not Th2 subset of CD4+ T cells. (29, 30 
